FALCONI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 12.407
EU - Europa 7.723
AS - Asia 6.672
SA - Sud America 3.436
AF - Africa 389
Continente sconosciuto - Info sul continente non disponibili 120
OC - Oceania 4
Totale 30.751
Nazione #
US - Stati Uniti d'America 12.136
BR - Brasile 2.739
VN - Vietnam 2.058
SG - Singapore 1.919
UA - Ucraina 1.666
RU - Federazione Russa 1.575
IE - Irlanda 821
DE - Germania 757
IT - Italia 707
DK - Danimarca 627
HK - Hong Kong 599
SE - Svezia 527
CN - Cina 477
TR - Turchia 453
FI - Finlandia 397
KR - Corea 329
FR - Francia 324
AR - Argentina 274
BD - Bangladesh 153
MA - Marocco 146
GB - Regno Unito 139
IN - India 132
ID - Indonesia 126
EC - Ecuador 121
CA - Canada 99
IQ - Iraq 98
CO - Colombia 92
MX - Messico 90
ZA - Sudafrica 78
PY - Paraguay 57
PK - Pakistan 54
EU - Europa 47
VE - Venezuela 45
AT - Austria 40
CL - Cile 37
PE - Perù 34
TN - Tunisia 34
CI - Costa d'Avorio 33
PH - Filippine 31
JP - Giappone 27
UY - Uruguay 26
UZ - Uzbekistan 26
EG - Egitto 24
PL - Polonia 24
DZ - Algeria 21
KE - Kenya 21
JO - Giordania 20
NL - Olanda 20
AE - Emirati Arabi Uniti 19
ES - Italia 19
KZ - Kazakistan 18
JM - Giamaica 15
TH - Thailandia 15
AL - Albania 14
SA - Arabia Saudita 13
BE - Belgio 12
BO - Bolivia 11
CR - Costa Rica 11
DO - Repubblica Dominicana 11
MY - Malesia 11
GT - Guatemala 10
LB - Libano 10
OM - Oman 10
BY - Bielorussia 9
NP - Nepal 9
AZ - Azerbaigian 8
BG - Bulgaria 7
CZ - Repubblica Ceca 7
HN - Honduras 7
RS - Serbia 7
SN - Senegal 7
TT - Trinidad e Tobago 7
TW - Taiwan 7
AM - Armenia 6
KG - Kirghizistan 6
PA - Panama 6
BA - Bosnia-Erzegovina 5
IL - Israele 5
SV - El Salvador 5
AU - Australia 4
BH - Bahrain 4
ET - Etiopia 4
GE - Georgia 4
PR - Porto Rico 4
PS - Palestinian Territory 4
RO - Romania 4
SY - Repubblica araba siriana 4
BW - Botswana 3
GN - Guinea 3
KH - Cambogia 3
KW - Kuwait 3
LT - Lituania 3
LV - Lettonia 3
BS - Bahamas 2
CG - Congo 2
CY - Cipro 2
EE - Estonia 2
GA - Gabon 2
IR - Iran 2
ML - Mali 2
Totale 30.651
Città #
Jacksonville 1.630
Ashburn 1.137
Fairfield 1.006
Singapore 975
Dublin 819
Council Bluffs 717
Ho Chi Minh City 700
Boardman 662
Hong Kong 593
Wilmington 498
Dallas 497
Hanoi 433
San Jose 433
Woodbridge 406
Houston 387
Seattle 358
Princeton 332
San Mateo 330
Lawrence 329
Chandler 307
Cambridge 288
Lauterbourg 285
Centro 277
Moscow 247
The Dalles 221
São Paulo 214
New York 192
Ann Arbor 164
San Diego 138
Des Moines 135
Hefei 127
Los Angeles 117
Milan 107
Da Nang 99
Beijing 94
Rio de Janeiro 86
Haiphong 83
Chicago 63
Curitiba 56
Helsinki 55
Brasília 48
Porto Alegre 48
Belo Horizonte 45
Guayaquil 42
Miano 42
Nuremberg 41
Biên Hòa 38
Phoenix 36
Quito 35
Thái Bình 34
Abidjan 33
London 33
Munich 33
Saint Petersburg 33
Salvador 33
Santa Clara 33
Baghdad 31
Campinas 30
Orem 30
Ribeirão Preto 30
Hải Dương 28
Johannesburg 26
São Bernardo do Campo 24
Denver 23
Guarulhos 23
Phủ Lý 23
Shanghai 23
Sorocaba 23
Tashkent 23
Thái Nguyên 23
Can Tho 22
Dhaka 22
Norwalk 22
Asunción 21
Brooklyn 21
Lima 21
Ninh Bình 21
Turku 21
Buenos Aires 20
Buffalo 20
Guangzhou 20
Manaus 20
Warsaw 20
Goiânia 19
Montreal 19
Rome 19
Vienna 19
Amman 18
Atlanta 18
Cape Town 18
Jakarta 18
Nairobi 18
Salt Lake City 18
Bắc Ninh 17
Fortaleza 17
Medellín 17
Santo André 17
Bogotá 16
Chennai 16
Columbus 16
Totale 17.135
Nome #
Teicoplanin concentrations in cholecystic, pancreatic and hepatic tissues 245
"PancPro" as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases. 175
Absence of mutations in the transforming growth factor-beta inducible early gene 1, TIEG1, in pancreatic cancer. 172
[Closed surgical treatment in acute severe pancreatitis] 168
A single istitution experience with fistulojejunostomy for external pancreatic fistulas 164
Adequacy of Lymph Node Retrieval for Ampullary Cancer and Its Association with Improved Staging and Survival. 158
Acute necrotizing pancreatitis and fistula treatment: the role of somatostatin - 14 and its analogues. 151
Acoustic radiation force impulse ultrasound imaging of pancreatic cystic lesions: preliminary results 149
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations. 148
Poorly differentiated resectable pancreatic cancer: Is upfront resection worthwhile? 145
Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms 143
Alchool intake,cigarette smoking and body mass index in patients with alcohol associated pancreatitis 142
A novel germline mutation, P48T, in the CDKN2A/p16 gene in a patient with pancreatic carcinoma. 141
Intraductal papillary mucinous neoplasms and chronic pancreatitis. 141
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. 141
A case of intraductal papillary mucinous tumour following recurrent attacks of pancreatitis lasting 26 years 136
Ultrasonography of the pancreas. 7. Intraoperative imaging. 134
International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. 134
Clinical and Patient-Reported Outcomes After Pancreatoduodenectomy for Different Diseases: A Follow-Up Study. 131
Italian consensus guidelines for chronic pancreatitis 130
Allelotype of ampulla of Vater cancer: highly frequent involvement of chromosome 11 130
Alcohol and smoking as risk factors in chronic pancreatitits and pancreatic cancer 130
B-Cell Lymphoma Presenting as Acute Pancreatitis. 130
Enhanced recovery pathways in pancreatic surgery: State of the art 130
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomized controlled trial 129
MTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors 129
Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: Data from a large international cohort study 129
Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian association for the study of the pancreas. 128
Multidisciplinary approach including receptor radionuclide therapy with 90Y-DOTATOC ([90Y-DOTA0, Tyr3]-octreotide) and 177Lu-DOTATATE ([177Lu-DOTA0, Tyr3]-octreotate) in ectopic cushing syndrome from a metastatic gastrinoma: a promising proposal. 126
Adenocarcinoma pancreatico umano primario ed espressione dell’ossido nitrico sintetasi inducibile e cicloossigenasi–2. 125
A preoperative score to predict early death after pancreatic cancer resection 125
Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. 124
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors 124
ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas. 123
Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study. 122
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. 120
Intraductal papillary mucinous neoplasms of the biliary and pancreatic ducts-A shape shifting outlook into an increasingly recognized disease. 117
Resectable pancreatic adenocarcinoma: depiction of tumoral margins at contrast-enhanced ultrasonography 117
Preoperative assessment of nonfunctioning pancreatic endocrine tumours: role of MDCT and MRI. 116
A systematic review on robotic pancreaticoduodenectomy. 116
Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study. 115
Alcohol intake, cigarette smoking, and body mass index in patients with alcohol-asociated pancreatitis 114
Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside. 113
The role of disease causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL. 113
Neuroendocrine Tumor Disease- An Evolving Landscape. 112
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms. 111
Role of Resection of the Primary Pancreatic Neuroendocrine Tumour Only in Patients with Unresectable Metastatic Liver Disease: A Systematic Review. 111
Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology 111
ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. 110
ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System. Well-Differentiated Pancreatic Non-Functioning Tumors. 109
Antimicrobial activity of human pancreatic juice and its interaction with antibiotics. 109
Minimally invasive necrosectomy versus conventional surgery in the treatment of infected pancreatic necrosis: a systematic review and a meta-analysis of comparative studies. 109
Prospective minimally invasive pancreatic resections from the IGOMIPS registry: a snapshot of daily practice in Italy on 1191 between 2019 and 2022 108
Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy 107
Ampulla of vater cancers: T-stage and histological subtype but not Dpc4 expression predict prognosis 107
Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. 107
Risk of misdiagnosis and overtreatment in patients with main pancreatic duct dilatation and suspected combined/main-duct intraductal papillary mucinous neoplasms 107
Surgical treatment of pancreatic tumors in childhood and adolescence: uncommon neoplasms with favorable outcome. 106
Cystic distrophy of the duodenal wall (CDDW): the Verona experience 106
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. 106
Allelotype of pancreatic acinar cell carcinoma. 106
Identification of a novel antibody associated with autoimmune pancreatitis 105
Pancreatoblastoma in adults: a review of the literature. 105
Smoking cessation at the clinical onset of chronic pancreatitis and risk of pancreatic calcifications 105
Anastomotic leakage in pancreatic surgery. 105
Faecal elastase-1 is an independent predictor of survival in advanced pancreatic cancer. 105
ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. 105
Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence. 105
Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors 105
Cancer Risk among the Relatives of Patients with Pancreatic Ductal Adenocarcinoma. 104
Previous cholecystectomy, gastrectomy, and diabetes mellitus are not crucial risk factors for pancreatic cancer in patients with chronic pancreatitis 104
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 104
Sonography versus helical CT in identification and staging of pancreatic ductal adenocarcinoma 104
Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary. 104
Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors. 104
Discussion on prophylactic antibiotic treatment in patients with predicted severe pancreatitis: a placebo-controlled, double-blind trial 103
Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas. 103
Treatment trends in metastatic pancreatic cancer patients: Is it time to change? 103
Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries 103
Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases. 103
MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases 102
Partial Pancreaticoduodenectomy Can Provide Cure for Duodenal Gastrinoma Associated With Multiple Endocrine Neoplasia Type 1. 102
Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor 102
Cisti splenica epiteliale 102
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. 102
Pancreas: Insulinoma--new insights into an old disease. 101
ENETS consensus guidelines for the management of peritoneal carcinomatosis from neuroendocrine tumors. 101
Questions about branch-duct IPMNs with Sendai negative criteria. 101
Outcomes of intraductal papillary mucinous neoplasm with "Sendai-positive" criteria for resection undergoing non-operative management. 101
Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. 100
In vivo octreotide administration acutely reduces exocrine granule size in the human pancreas 100
Long-term results of Frey's procedure for chronic pancreatitis: a longitudinal prospective study on 40 patients. 100
Cystic distrophy of the duodenal wall (CDDW): the Verona experience 100
Current status of robotic distal pancreatectomy: a systematic review. 100
Comparison of contrast-enhanced sonography and MRI in displaying anatomic features of cystic pancreatic masses 99
Contrast-enhanced ultrasonography in the characterization of pancreatic mucinous cystadenoma 99
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. 99
Well-differentiated pancreatic nonfunctioning tumors/carcinoma 98
Ofloxacin penetration into bile and pancreatic juice. 97
Neuroendocrine pancreatic tumor: value of contrast enhanced ultrasonography. 97
Totale 11.817
Categoria #
all - tutte 150.932
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 150.932


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.386 0 0 12 93 3 179 78 149 116 209 51 496
2022/20231.886 367 189 228 61 56 120 2 32 736 3 49 43
2023/20241.386 328 7 32 349 325 145 18 9 1 8 4 160
2024/20253.651 227 535 39 9 66 21 521 105 1.113 252 299 464
2025/202611.401 498 1.145 1.202 2.765 358 451 1.719 1.136 681 815 115 516
2026/20271.752 862 580 310 0 0 0 0 0 0 0 0 0
Totale 30.751